Industry
Biotechnology
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Loading...
Open
0.24
Mkt cap
11M
Volume
315K
High
0.26
P/E Ratio
-0.87
52-wk high
3.56
Low
0.24
Div yield
N/A
52-wk low
0.19
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.